EnVVeno Research Development from 2010 to 2026

NVNO Stock  USD 11.50  0.21  1.86%   
EnVVeno Medical Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to grow to about 14.8 M this year. During the period from 2010 to 2026, EnVVeno Medical Research Development quarterly data regression pattern had sample variance of 31.4 T and median of  1,238,749. View All Fundamentals
 
Research Development  
First Reported
2017-03-31
Previous Quarter
2.9 M
Current Value
2.6 M
Quarterly Volatility
1.3 M
 
Covid
 
Interest Hikes
Check EnVVeno Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnVVeno Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 351.6 K, Interest Expense of 224.9 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 7.61, Dividend Yield of 0.0 or PTB Ratio of 0.0337. EnVVeno financial statements analysis is a perfect complement when working with EnVVeno Medical Valuation or Volatility modules.
  
Build AI portfolio with EnVVeno Stock
Check out the analysis of EnVVeno Medical Correlation against competitors.
Evaluating EnVVeno Medical's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into enVVeno Medical Corp's fundamental strength.

Latest EnVVeno Medical's Research Development Growth Pattern

Below is the plot of the Research Development of enVVeno Medical Corp over the last few years. It is EnVVeno Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EnVVeno Medical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

EnVVeno Research Development Regression Statistics

Arithmetic Mean4,896,804
Geometric Mean2,211,966
Coefficient Of Variation114.51
Mean Deviation4,819,981
Median1,238,749
Standard Deviation5,607,143
Sample Variance31.4T
Range14.1M
R-Value0.89
Mean Square Error7.1T
R-Squared0.79
Slope986,514
Total Sum of Squares503T

EnVVeno Research Development History

202614.8 M
202514.1 M
202412.2 M
202313.6 M
20229.9 M
20215.7 M
20204.3 M

About EnVVeno Medical Financial Statements

EnVVeno Medical investors utilize fundamental indicators, such as Research Development, to predict how EnVVeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development14.1 M14.8 M

Pair Trading with EnVVeno Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with EnVVeno Stock

  0.74IL3 Integra LifeSciences Earnings Call TomorrowPairCorr
  0.75EW Edwards Lifesciences Corp Sell-off TrendPairCorr

Moving against EnVVeno Stock

  0.69HYB HOYAPairCorr
  0.38DXCM DexCom IncPairCorr
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out the analysis of EnVVeno Medical Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could EnVVeno diversify its offerings? Factors like these will boost the valuation of EnVVeno Medical. Anticipated expansion of EnVVeno directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every EnVVeno Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(37.80)
Return On Assets
(0.35)
Return On Equity
(0.57)
Understanding enVVeno Medical Corp requires distinguishing between market price and book value, where the latter reflects EnVVeno's accounting equity. The concept of intrinsic value - what EnVVeno Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push EnVVeno Medical's price substantially above or below its fundamental value.
It's important to distinguish between EnVVeno Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EnVVeno Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EnVVeno Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.